RDGL
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
46.65M
SAFLY
Price
$3.39
Change
+$1.10 (+48.03%)
Updated
Aug 21 closing price
Capitalization
707.85M
Interact to see
Advertisement

RDGL vs SAFLY

Header iconRDGL vs SAFLY Comparison
Open Charts RDGL vs SAFLYBanner chart's image
Vivos
Price$0.10
Change-$0.00 (-0.00%)
Volume$276.62K
Capitalization46.65M
Safilo Group Spa
Price$3.39
Change+$1.10 (+48.03%)
Volume$121
Capitalization707.85M
RDGL vs SAFLY Comparison Chart in %
Loading...
RDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RDGL vs. SAFLY commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDGL is a Hold and SAFLY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (RDGL: $0.10 vs. SAFLY: $3.39)
Brand notoriety: RDGL and SAFLY are both not notable
RDGL represents the Medical/Nursing Services, while SAFLY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RDGL: 14% vs. SAFLY: 115%
Market capitalization -- RDGL: $46.65M vs. SAFLY: $707.85M
RDGL [@Medical/Nursing Services] is valued at $46.65M. SAFLY’s [@Pharmaceuticals: Other] market capitalization is $707.85M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RDGL’s FA Score shows that 0 FA rating(s) are green whileSAFLY’s FA Score has 0 green FA rating(s).

  • RDGL’s FA Score: 0 green, 5 red.
  • SAFLY’s FA Score: 0 green, 5 red.
According to our system of comparison, SAFLY is a better buy in the long-term than RDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RDGL’s TA Score shows that 5 TA indicator(s) are bullish while SAFLY’s TA Score has 2 bullish TA indicator(s).

  • RDGL’s TA Score: 5 bullish, 6 bearish.
  • SAFLY’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, SAFLY is a better buy in the short-term than RDGL.

Price Growth

RDGL (@Medical/Nursing Services) experienced а -7.64% price change this week, while SAFLY (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Industries' Descriptions

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAFLY($708M) has a higher market cap than RDGL($46.7M). SAFLY YTD gains are higher at: 52.018 vs. RDGL (-10.531). SAFLY has higher annual earnings (EBITDA): 107M vs. RDGL (-3.04M). SAFLY has more cash in the bank: 72.6M vs. RDGL (2.66M). RDGL has less debt than SAFLY: RDGL (296K) vs SAFLY (115M). SAFLY has higher revenues than RDGL: SAFLY (999M) vs RDGL (51.7K).
RDGLSAFLYRDGL / SAFLY
Capitalization46.7M708M7%
EBITDA-3.04M107M-3%
Gain YTD-10.53152.018-20%
P/E RatioN/A12.98-
Revenue51.7K999M0%
Total Cash2.66M72.6M4%
Total Debt296K115M0%
FUNDAMENTALS RATINGS
RDGL vs SAFLY: Fundamental Ratings
RDGL
SAFLY
OUTLOOK RATING
1..100
537
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
7344
SMR RATING
1..100
9970
PRICE GROWTH RATING
1..100
8637
P/E GROWTH RATING
1..100
79100
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SAFLY's Valuation (64) in the null industry is in the same range as RDGL (94). This means that SAFLY’s stock grew similarly to RDGL’s over the last 12 months.

SAFLY's Profit vs Risk Rating (44) in the null industry is in the same range as RDGL (73). This means that SAFLY’s stock grew similarly to RDGL’s over the last 12 months.

SAFLY's SMR Rating (70) in the null industry is in the same range as RDGL (99). This means that SAFLY’s stock grew similarly to RDGL’s over the last 12 months.

SAFLY's Price Growth Rating (37) in the null industry is somewhat better than the same rating for RDGL (86). This means that SAFLY’s stock grew somewhat faster than RDGL’s over the last 12 months.

RDGL's P/E Growth Rating (79) in the null industry is in the same range as SAFLY (100). This means that RDGL’s stock grew similarly to SAFLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RDGLSAFLY
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
25%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
13%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
13%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
RDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TDSGF0.060.01
+10.62%
Telo Genomics Corp.
FUJIF24.05N/A
N/A
FUJIFILM Holdings Corp.
VLXGF4.73N/A
N/A
Volex Group Plc.
ZHSHF1.35N/A
N/A
Zhongsheng Group Holdings Ltd
BLGO0.22N/A
-1.22%
BioLargo, Inc.

RDGL and

Correlation & Price change

A.I.dvisor tells us that RDGL and RYLPF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDGL and RYLPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDGL
1D Price
Change %
RDGL100%
+1.78%
RYLPF - RDGL
7%
Poorly correlated
N/A
SAFLY - RDGL
5%
Poorly correlated
N/A
POSC - RDGL
2%
Poorly correlated
+1.29%
SARTF - RDGL
2%
Poorly correlated
N/A
PLLWF - RDGL
-3%
Poorly correlated
N/A
More

SAFLY and

Correlation & Price change

A.I.dvisor tells us that SAFLY and TCHBF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLY and TCHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLY
1D Price
Change %
SAFLY100%
N/A
TCHBF - SAFLY
29%
Poorly correlated
N/A
LZAGY - SAFLY
27%
Poorly correlated
+0.64%
CNVVF - SAFLY
26%
Poorly correlated
N/A
RVTY - SAFLY
26%
Poorly correlated
+1.10%
LZAGF - SAFLY
22%
Poorly correlated
-0.87%
More